Induction of P-glycoprotein mRNA transcripts by cycloheximide in animal tissues: Evidence that class I Pgp is transcriptionally regulated whereas class II Pgp is post-transcriptionally regulated

Molecular and Cellular Biochemistry

Volumn 216, Issue 1-2, 2001, Pages 103-110

  Lee, C H ^a  

^a UNIVERSITY OF NORTHERN BRITISH COLUMBIA   (Canada)

Author keywords

Animal tissues; Cycloheximide; Multidrug resistance; P glycoprotein; Post transcription; Transcription

Indexed keywords

CYCLOHEXIMIDE; GLYCOPROTEIN P; GLYCOPROTEIN PGP1; GLYCOPROTEIN PGP2; GLYCOPROTEIN PGP3; MESSENGER RNA; PROTEIN SUBUNIT; PROTEIN SYNTHESIS INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG TRANSPORT; GENE EXPRESSION REGULATION; MALE; MULTIDRUG RESISTANCE; NONHUMAN; PROTEIN INDUCTION; PROTEIN PROCESSING; RAT; REGULATOR GENE; TRANSCRIPTION REGULATION;

ANIMALS; CELL NUCLEUS; CYCLOHEXIMIDE; GENE EXPRESSION REGULATION; MALE; P-GLYCOPROTEINS; PROTEIN ISOFORMS; RATS; RATS, INBRED F344; RIBONUCLEASES; RNA; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA, MESSENGER; TIME FACTORS; TISSUE DISTRIBUTION; TRANSCRIPTION, GENETIC;

ANIMALIA;

EID: 0035122209     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011086716568     Document Type: Article

References (52)

1. The biochemistry of P-glycoprotein-mediated multidrug resistance
2. The multidrug transporter, a double-edged sword
3. Hepatic canalicular membrane 4: Expression of the multidrug resistance genes in the liver
4. Biochemical, cellular, and pharmacological aspects of the multidrug transporter
5. An inventory of the human ABC proteins
6. Multidrug resistance: Molecular mechanisms and clinical relevance
7. MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine
8. The physiological function of drug-transporting P-glycoproteins
9. Pharmacological insights from P-glycoprotein knockout mice
10. The direct activation of human multidrug resistance gene (MDR1) by anticancer agents
11. Regulation of mdr RNA levels in response to cytotoxic drugs in rodent cells
12. Up-regulation of P-glycoprotein expression in rat liver cells by acute doxorubicin treatment
13. Multidrug resistance gene expression in rodents and rodent hepatocytes treated with mitoxantrone
14. Bromocriptine transcriptionally activates the multidrug resistance gene (pgp2/mdr1b) by a novel pathway
15. Regulation of 2-acetylaminofluorene- and 3-methylcholanthrene-mediated induction of multidrug resistance and cytochrome P 450IA gene family expression in primary hepatocyte cultures and rat liver
16. Expression of multidrug resistance genes in rat liver during regeneration and after carbon tetrachloride intoxication
17. Enhanced expression of the multidrug resistance gene in response to UV light irradiation
18. Heat shock and arsenite increase expression of the multidrug resistance (MDR1) gene in human renal carcinoma cells
19. Targetted disruption of the mouse mdr1 b gene reveals that steroid hormone enhance mdr gene expression
20. Modulation ofmultidrug resistance gene expression by dexamethasone in cultured hepatoma cells
21. Divergent regulation of the class II P-glycoprotein gene in primary cultures of hepatocytes versus H35 hepatoma by glucocorticoids
22. Enhanced expression by the brain matrix of P-glycoprotein in brain capillary endothelial cells
23. Extracellular matrix regulation of multidmg resistance in primary monolayer cultures of adult rat hepatocytes
24. Characterization of the basal and carcinogen regulatory elements of the rat mdr1 b promoter
25. Modulation of the activity of the promoter of the human MDR1 gene by Ras and p53
26. Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR1 gene expression
27. Sp1 and erg-1 have opposing effects on the regulation of the rat Pgp2/mdr1 b gene
28. Constitutive expression of functional P-glycoprotein in rat hepatoma cells
29. Activation of distinct multidrug-resistance (P-glycoprotein) genes during rat liver regeneration and hepatocarcinogenesis
30. Cellular patterns of multidrug-resistance gene expression daring chemical hepatocaminogenesis in the rat
31. Regulation of the multidrug resistance gene in regenerating rat liver
32. The three mouse multidrug resistance (mdr) genes are expressed in a tissue-specific manner in normal mouse tissues
33. Differential expression of Pglycoprotein genes in primary rat hepatocyte culture
34. Regulation of mdr1b gene expression in Fischer, Wistar and Sprague-Dawley rats in vivo and in vitro
35. Overexpression of the class II P-glycoprotein gene in primary rat hepatocyte culture: Evidence for increased mRNA stability
36. Alterations in mRNA stability during rat liver regeneration
37. Increased P-glycoprotein messenger RNA stability in rat liver tumors in vivo
38. Regulation of multi-drug resistance gene mdr1b/mdr1 expression in isolated mouse uterine epithelial cells
39. Differences between nuclear run-off and mRNA levels for multidrug resistance gene expression in the cephalocaudal axis of the mouse intestine
40. A hypothesis to explain why translation inhibitors stabilize mRNAs in mammalian cells: MRNA stability and mitosis
41. Regulation of P-glycoprotein gene expression in hepatocyte cultures and liver cell lines by a trans-acting transcriptional repressor
42. Induction of P-glycoprotein mRNA by protein synthesis inhibition is not controlled by a transcriptional repressor protein in rat and human liver cells
43. Differential regulation of multiple gap junction transcripts and proteins during rat liver regeneration
44. Posttranscriptional regulation of cyclin B messenger RNA expression in the regenerating rat liver
45. Transcriptional regulation of transferrin and albumin genes by retinoic acid in human hepatoma-cell line Hep 3B
46. The down-regulation of albumin transcription during regeneration is due to the loss of HNF-1 and the D-site transcription factors
47. The AU-rich 3′ untranslated region of human MDR1 mRNA is an inefficient mRNA destabilizer
48. MRNA degradation: A tale of poly(A) and multiprotein machines
49. Protein synthesis inhibitors differentially superinduce c-fos and c-jun by three distinct mechanisms: Lack of evidence for labile repressors
50. Characterization of the rat mdr 2 promoter and its regulation by the transcription factor Sp1
51. Induction of pgp3 expression and reversion of the multidrug resistance phenotype in 9-O-Hellipticine-resistant Chinese hamster lung fibroblasts transfected with the MYC oncogene
52. Differential regulation and expression of jun, c-fos and c-myc proto-oncogenes during mouse liver regeneration and after inhibition of protein synthesis